EMAIL THIS PAGE TO A FRIEND

PloS one

SHP-2 Mediates Cryptosporidium parvum Infectivity in Human Intestinal Epithelial Cells.


PMID 26556238

Abstract

The parasite, Cryptosporidium parvum, induces human gastroenteritis through infection of host epithelial cells in the small intestine. During the initial stage of infection, C. parvum is reported to engage host mechanisms at the host cell-parasite interface to form a parasitophorous vacuole. We determined that upon infection, the larger molecular weight proteins in human small intestinal epithelial host cells (FHs 74 Int) appeared to globally undergo tyrosine dephosphorylation. In parallel, expression of the cytoplasmic protein tyrosine phosphatase Src homology-2 domain-containing phosphatase 2 (SHP-2) increased in a time-dependent manner. SHP-2 co-localized with the C. parvum sporozoite and this interaction increased the rate of C. parvum infectivity through SH2-mediated SHP-2 activity. Furthermore, we show that one potential target that SHP-2 acts upon is the focal adhesion protein, paxillin, which undergoes moderate dephosphorylation following infection, with inhibition of SHP-2 rescuing paxillin phosphorylation. Importantly, treatment with an inhibitor to SHP-2 and with an inhibitor to paxillin and Src family kinases, effectively decreased the multiplicity of C. parvum infection in a dose-dependent manner. Thus, our study reveals an important role for SHP-2 in the pathogenesis of C. parvum. Furthermore, while host proteins can be recruited to participate in the development of the electron dense band at the host cell-parasite interface, our study implies for the first time that SHP-2 appears to be recruited by the C. parvum sporozoite to regulate infectivity. Taken together, these findings suggest that SHP-2 and its down-stream target paxillin could serve as targets for intervention.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2700022
Anti-NS1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2700186
Anti-NS1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2700193
Anti-NS1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB4502553
Anti-Paxillin antibody produced in rabbit, affinity isolated antibody
SAB4300559
Anti-PTPN11 (Ab-542) antibody produced in rabbit, affinity isolated antibody
SAB4300560
Anti-PTPN11 (Ab-580) antibody produced in rabbit, affinity isolated antibody
SAB2900281
Anti-PTPN11 (AB1) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2900375
Anti-PTPN11 (AB2) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
GW21495A Anti-PTPN11 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB1406345
Anti-PTPN11 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB4300384
Anti-PXN (Ab-118) antibody produced in rabbit, affinity isolated antibody
SAB4300459
Anti-PXN (Ab-31) antibody produced in rabbit, affinity isolated antibody
SAB4300592
Anti-PXN (Ab-88) antibody produced in rabbit, affinity isolated antibody
SAB1406355
Anti-PXN antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB4502536
Anti-SH-PTP2 antibody produced in rabbit, affinity isolated antibody
SAB4502534
Anti-SHP-2, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4502535
Anti-SHP-2, C-Terminal antibody produced in rabbit, affinity isolated antibody
PRS3901
Anti-SHP2 (ab1) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
PRS3903
Anti-SHP2 (ab2) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1301000
Anti-SHP2 (Y584) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1300500
Anti-SHP2 antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB1306770
ANTI-SHP2 antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
D8284
Bicinchoninic acid disodium salt hydrate, ≥98% (HPLC)
C20H10N2Na2O4 · xH2O
145726
DL-Tyrosine, 99%
C9H11NO3
G3126
L-Glutamine, ReagentPlus®, ≥99% (HPLC)
C5H10N2O3
G5792
L-Glutamine, PharmaGrade, Ajinomoto, USP, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production, suitable for cell culture
C5H10N2O3
G8540
L-Glutamine, meets USP testing specifications, cell culture tested, 99.0-101.0%, from non-animal source
C5H10N2O3
G6392
L-Glutamine, γ-irradiated, BioXtra, suitable for cell culture
C5H10N2O3
49419
L-Glutamine, BioUltra, ≥99.5% (NT)
C5H10N2O3
W368401
L-Glutamine
C5H10N2O3